Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Sun Pharma Advanced Research Company Limited, is a listed public company incorporated on 01 March, 2006. It is classified as a public limited company and is located in Vadodara, Gujarat. It's authorized share capital is INR 42.50 cr and the total paid-up capital is INR 32.45 cr.
Sun Pharma Advanced Research Company Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's book networth has decreased by 106.29%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Sudhir Vrundavandas Valia
Shareholder
|
00005561 | 11 years |
Managing Director | Dilip Shantilal Shanghvi
Shareholder
|
00005588 | 19 years |
CFO | Chetan Manharlal Rajpara
Shareholder
|
<HIDDEN> | 8 years |
Director | Ferzaan Nariman Engineer | 00025758 | 8 years |
Director | Bhavna Gautam Doshi | 00400508 | 11 years |
Director | Rajamannar Thennati
Shareholder
|
01415412 | 18 years |
Kmp | Anil Kumar | <HIDDEN> | 4 years |
Kmp | Kajal Kiran Damania | <HIDDEN> | 2 years |
Director | Robert Jay Spiegel | 08739625 | 5 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 150.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 25.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SPARCLIFE Inc. | United States | - | - |
Read more
The incorporation date of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is 01 March, 2006
The authorized share capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 42.5 Cr.
The paid-up capital of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is INR ₹ 32.5 Cr.
The registered address of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway Manjusar Vadodara Gujarat - 391775
The CIN number of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED is L73100GJ2006PLC047837.